Distinct brain morphometric similarity network phenotypes are associated with mild cognitive impairment in type 2 diabetes mellitus

Introduction Patients with type 2 diabetes mellitus (T2DM) exhibit heterogeneous brain alterations and cognitive dysfunction, complicating the characterization of their associations with mild cognitive impairment (MCI). Objective To identify imaging-defined subtypes of T2DM-related brain alterations and investigate their associations with MCI. Methods A total of 490 patients with T2DM and 288 healthy controls were included. Individual-level morphometric similarity networks (MSNs) were constructed from cortical morphological features, including gray matter volume, surface area, cortical thickness, and mean curvature. Heterogeneity through discriminative analysis was applied to identify subtypes of T2DM-related brain alteration based on MSNs. Group differences were assessed using general linear models. Multivariable logistic regression evaluated the associations between brain alteration subtypes and MCI. Linear regression and mediation analyses assessed associations among MSN alterations, metabolic markers, and cognitive function. Results Two distinct subtypes of T2DM-related brain alterations were identified, revealing divergent patterns of MSN reorganization and cognitive impairment. T2DM1 was characterized by increased MSN strength and relatively preserved cognition, whereas T2DM2 exhibited widespread MSN reductions and higher odds of MCI. The visual, somatomotor, and ventral attention networks contributed to subtype differentiation and showed distinct associations with glycated hemoglobin, glucose response, and insulin-related measures. Reduced limbic network MSN strength emerged specifically in T2DM2 and was associated with poorer cognition and higher odds of MCI, while mediating the association between hyperglycemia and cognitive function. Conclusions T2DM-related brain alterations exhibit two distinct MSN phenotypes with different odds of MCI. In the phenotype marked by widespread MSN reductions and lower MMSE scores, reduced limbic network MSN strength may serve as an imaging marker of the association between metabolic dysfunction and cognitive impairment.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-12
DOI
https://doi.org/10.3389/fendo.2026.2014196
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Distinct brain morphometric similarity network phenotypes are associated with mild cognitive impairment in type 2 diabetes mellitus

Xiaomei Yue, Zifeng Qiu, Gang Li, Shijun Qiu et al.
Frontiers in Endocrinology
Dementia and Cognitive Impairment Research
article

Distinct brain morphometric similarity network phenotypes are associated with mild cognitive impairment in type 2 diabetes mellitus

Xiaomei Yue, Zifeng Qiu, Gang Li, Shijun Qiu, Zhao Dai
article en

Abstract

Introduction Patients with type 2 diabetes mellitus (T2DM) exhibit heterogeneous brain alterations and cognitive dysfunction, complicating the characterization of their associations with mild cognitive impairment (MCI). Objective To identify imaging-defined subtypes of T2DM-related brain alterations and investigate their associations with MCI. Methods A total of 490 patients with T2DM and 288 healthy controls were included. Individual-level morphometric similarity networks (MSNs) were constructed from cortical morphological features, including gray matter volume, surface area, cortical thickness, and mean curvature. Heterogeneity through discriminative analysis was applied to identify subtypes of T2DM-related brain alteration based on MSNs. Group differences were assessed using general linear models. Multivariable logistic regression evaluated the associations between brain alteration subtypes and MCI. Linear regression and mediation analyses assessed associations among MSN alterations, metabolic markers, and cognitive function. Results Two distinct subtypes of T2DM-related brain alterations were identified, revealing divergent patterns of MSN reorganization and cognitive impairment. T2DM1 was characterized by increased MSN strength and relatively preserved cognition, whereas T2DM2 exhibited widespread MSN reductions and higher odds of MCI. The visual, somatomotor, and ventral attention networks contributed to subtype differentiation and showed distinct associations with glycated hemoglobin, glucose response, and insulin-related measures. Reduced limbic network MSN strength emerged specifically in T2DM2 and was associated with poorer cognition and higher odds of MCI, while mediating the association between hyperglycemia and cognitive function. Conclusions T2DM-related brain alterations exhibit two distinct MSN phenotypes with different odds of MCI. In the phenotype marked by widespread MSN reductions and lower MMSE scores, reduced limbic network MSN strength may serve as an imaging marker of the association between metabolic dysfunction and cognitive impairment.

Frontiers in EndocrinologyVol. 17
University of North Carolina at Chapel Hill (US), Guangzhou University of Chinese Medicine (CN), Guangzhou University (CN), First Affiliated Hospital of Guangzhou University of Chinese Medicine (CN)
Good health and well-being
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon